(2014). Adverse prognosis of incidentally detected ambulatory atrial fibrillation. A cohort study. Thromb Haemost. http://doi.org/10.1160/th4-04-0383.
(2015). Increasing incidence of non-valvular atrial fibrillation in the UK from 2001 to 2013. Heart. http://doi.org/10.1136/heartjnl-2015-307808.
(2016). Testosterone treatment and risk of venous thromboembolism: population based case-control study. Bmj. http://doi.org/10.1136/bmj.i5968.
(2016). Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study. Thromb Haemost. http://doi.org/10.1160/th15-04-0350.
(2016). Residual Risk of Stroke and Death in Anticoagulant-Treated Patients With Atrial Fibrillation. JAMA Cardiol. http://doi.org/10.1001/jamacardio.2016.0393.
(2016). Risk of recurrent venous thromboembolism after discontinuation of vitamin K antagonist treatment: a nested case-control study. J Thromb Haemost. http://doi.org/10.1111/jth.13337.
(2017). Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study. Thromb Haemost. http://doi.org/10.1160/th15-08-0686.
(2018). Thirteen-year trend in the persistence with vitamin K antagonists for venous thromboembolism in the UK: a cohort study. Curr Med Res Opin. http://doi.org/10.1080/03007995.2018.1481375.
(2019). Incident Atrial Fibrillation, Dementia and the Role of Anticoagulation: A Population-Based Cohort Study. Thromb Haemost. http://doi.org/10.1055/s-0039-1683429.
(2020). Variation in the Association between Antineoplastic Therapies and Venous Thromboembolism in Patients with Active Cancer. Thromb Haemost. http://doi.org/10.1055/s-0040-1709527.